Form 4: Amerant Bancorp Insider Trades Class A Stock

Sentiment:

Statement of Changes in Beneficial Ownership


Michael E. Nursey, SEVP and Chief Domestic Banking Officer of Amerant Bancorp Inc., reported transactions involving Class A Common Stock and Restricted Stock Units.

Summary

  • Michael E. Nursey, SEVP and Chief Domestic Banking Officer, engaged in transactions related to Amerant Bancorp Inc. Class A Common Stock.
  • On June 17, 2026, 1,343 shares of Class A Common Stock were acquired with a transaction code 'M' and a price of $0, representing the economic equivalent of restricted stock units (RSUs).
  • Also on June 17, 2026, 328 shares of Class A Common Stock were disposed of with a transaction code 'F' at a price of $23.23, which were surrendered to satisfy tax withholding obligations upon RSU vesting.
  • Following these transactions, Nursey beneficially owns 3,114 shares of Class A Common Stock directly.
  • Additionally, Nursey was awarded 6,716 RSUs on June 17, 2024, with a vesting schedule of 20% on the first two anniversaries and 60% on the third anniversary, provided continuous service.
  • After accounting for the RSUs, Nursey's total beneficial ownership of Class A Common Stock is 4,030 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents standard executive compensation and tax settlement transactions rather than significant strategic shifts or market-moving events.

Positives

  • Award of 6,716 Restricted Stock Units (RSUs) to Michael E. Nursey, indicating a long-term incentive and retention strategy.
  • Vesting schedule for RSUs provides ongoing incentives over three years.
  • The acquisition of 1,343 shares of Class A Common Stock via RSUs at $0 cost suggests compensation-related issuance.

Negatives

  • Surrender of 328 shares of Class A Common Stock to cover tax withholding obligations upon RSU vesting, representing a reduction in the net shares received by the executive.

Future Outlook

The vesting schedule for the 6,716 RSUs awarded on June 17, 2024, indicates future potential share issuances to Michael E. Nursey over the next three years, contingent on continued service.

Management Comments

  • Michael E. Nursey is the SEVP and Chief Domestic Banking Officer.
  • The filing is signed by Julio Pena as Attorney-in-Fact for Michael E. Nursey.

Industry Context

StockSavvy.ai notes that this Form 4 filing details routine insider transactions, specifically the acquisition of shares through restricted stock units and the settlement of tax obligations. Such filings are common for executives and provide transparency into their holdings and compensation-related share movements within the banking sector.

Stakeholder Impact

  • Shareholders: Increased transparency into executive compensation and share ownership.
  • Employees: Potential indication of executive retention and incentive programs.
  • Management: Standard reporting of compensation-related share transactions.

Next Steps

  • Vesting of 20% of the awarded RSUs on the first anniversary of the grant date (June 17, 2025).
  • Vesting of another 20% of the awarded RSUs on the second anniversary of the grant date (June 17, 2026).
  • Vesting of the remaining 60% of the awarded RSUs on the third anniversary of the grant date (June 17, 2027).

Key Dates

DateDescription
06/17/2024Date of grant for 6,716 Restricted Stock Units (RSUs).
06/17/2026Transaction date for acquisition of 1,343 Class A Common Stock (RSUs) and disposition of 328 Class A Common Stock (tax withholding).
06/18/2026Date of filing signature.

Keywords

Amerant Bancorp Inc., AMTB, Form 4, Insider Trading, Class A Common Stock, Restricted Stock Units, RSU Vesting, Beneficial Ownership, Executive Compensation, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.